Dasha Klebaner, MD, MPH
@dashaklebaner
She/hers. @ucsdMedSchool MD, @EmoryRollins MPH. PGY3 @StanfordRadOnc. sarcasm, equity, statistics, omics, my kids, rescue animals.
ID: 1284169459654029313
17-07-2020 16:54:15
1,1K Tweet
900 Followers
713 Following
I’m so excited to join the GR team, to learn and advance our shared policy & advocacy priorities 🤓 🙌🏽🎙️☢️ UW Department of Human Oncology
📢The string of GREAT papers in the IJROBP - The Red Journal is just not ending😅 🔥Phase II trial of #radiotherapy added to #immunotherapy for metastatic #lungcancer🔥 Michael Gensheimer Bill Loo MD PhD ⚡️☢️ Max Diehn, MD/PhD Stanford Radiation Oncology Timothy Chan Salma Jabbour Cliff Robinson redjournal.org/article/S0360-…
Important look at unanalyzed treatments Off-protocol RT allowed in 52% of trials, predominantly industry sponsored; reported in 2% Associated with higher likelihood of meeting primary endpoint redjournal.org/article/S0360-… Alexander Sherry Eugene J. Koay, MD, PhD Chad Tang, MD Pavlos Msaouel Ethan Ludmir MD
In awe of Zachary B. White II, MD, MS and his impactful leadership. As a Stanford Radiation Oncology Residents he’s led the charge representing ARRO and ASTRO & will continue to bring transformative change as a WhiteHouse Fellow to the Department of Veteran Affairs. Proud moment for #RadOnc 💪🏽🔥☢️🧬.
Not uncommon for an oligomet/progress pt on early drug trial to get MDT to all Mets, and the pt’s response is attributed to the drug. Some trials safeguard against this, but not all. Wondering if other see this Neil Desai Shankar Siva Amar Kishan Pierre Blanchard, MD Pavlos Msaouel
Be more Tyler Seibert MD PhD - one of the kindest most thoughtful people you will meet.